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Efficient elimination of foreign substances or organisms is the hallmark of an
effective immune response . Most responses are initiated by inducerT cells that
corecognize foreign determinants and I region products on antigen-presenting
cells (APC)' (1-3) . A lymphokine produced by inducer cells as a result of this
interaction is macrophage-activating factor (MAF) (4--6) . MAF activates macro-
phages to express lytic activity after a second `triggering' signal such as phago-
cytosis (7-10) . Lysis by activated macrophages is an important element of
resistance to bacteria, parasites, and tumor cells (11-16) .
An equally important component of macrophage-mediated protection is the
prevention of excessive immunologic damage to host tissues, once the foreign
agent has been eliminated (17) . In principle, activated macrophages that destroy
infected or cancerous cells might also dampen immune responses by lysing
inducer cells that initiate the responses . We have tested this hypothesis using
clones of hapten-specific inducer T cells and APC . We find that corecognition
of antigen and class II major histocompatibility complex (MHC) products on a
subset of APC results in (a) production of MAF (and other lymphokines), (b)
triggering of macrophage-mediated cytolysis, and (c) death of the inducer clone .
We suggest that this sequence of interactions may limit the duration of specific
immune responses by thedepletion of inducerT cells that are required to initiate
and maintain them .
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Materials and Methods
Mice .
￿
Female C57B1/6 (B6), BALB/c, A/J, and (BALB/c x A/J)F, (CAF,) mice were
obtained from TheJackson Laboratory, Bar Harbor, ME, and used at 6 wk to 4 mo of
age .
Antigens.
￿
p-Arsanilic and p-sulphanilic acid (AR, SA) (Eastman Laboratory and Spe-
cialty Chemicals, Rochester, NY) were diazotized and conjugated to bovine gamma
globulin (BGG) (Sigma ChemicalCo ., St . Louis, MO)as described (18) . Haptenation ratios
(moles [AR-TYR + AR-HIS]/mole protein) were estimated using an extinction coefficient
* Supported by grants AI 13600,CA 26695, and AI 12184 from the National Institutes of Health.
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APC, antigen-presenting cells ; AR, p-azobenzenearsonate ; BCG,
bacillus Calmette-Guerin ; BGG, bovine gamma globulin ; Con A, concanavalin A ; DME, Dulbecco's
modified Eagle's medium ; IL-1, IL-2, interleukin 1 and 2 ; KLH, keyhole limpet hemocyanin ; MAF,
macrophage-activating factor(s) ; MHC, major histocompatibility complex; MLR, mixed lymphocyte
reaction ; PMA, phorbol myristate acetate ; SA, p-azobenzenesulphonate .
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of 8.15 mM- ' in 0.1 N NaOH at the isosbestic point of 350 nm (19) .
Monoclonal Antibodies and Antisera.
￿
Cells of the hybridomas 14.4.4s (I-Ed .k .P , r:Ia.7) (20)
and MKD6 (I-Ad,9Ja.16) (21 and unpublished results) were cultured in RPMI 1640 with
10% gamma globulin-free horse serum or 10% fetal calf serum . Antibodies were purified
from culture supernatants using protein A-Sepharose or DEAF cellulose . Culture super-
natant of the hybridoma 10.2.16 (I-A') (22) was a gift from R . Rosenson, Tufts University
Medical Center .
Derivation and Culture of Arsonate-reactive T Cell Clones. CAF, mice suppressed for
production of the cross-reactive idiotype for arsonate were a kind gift from Dr . A .
Marshak-Rothstein and Dr . M . Gefter . CAF, mice were suppressed with a single intraper-
itoneal injection of monoclonal antiidiotype (23) and immunized with 100 tug ofAR-KLH
(keyhole limpet hemocyanin) in Freund's complete adjuvant intraperitoneally 18 d later .
Clone Lyl/A5 was derived from singly immunized mice while clone Lyl/A7 was
obtained from hyperimmune animals . Immune spleen cells were cultured at a concentra-
tion of 5 X 10' cells/ml in Dulbecco's modified Eagle's medium (DME) containing 10%
selected fetal calfserum and additives (Gibco Laboratories, Grand Island, NY) as described
(24) and 50 ug/ml AR-BGG . Cells surviving after 8 d of culture were recultured at 2 X
105/well with 5 X 106 irradiated (2,000 rad) CAF, spleen cells/well in 24-well culture
dishes (Linbro Chemical Co ., Hamden, CT) in medium containing 50 Ag/ml AR-BGG as
above . Arsonate-reactive T cells were maintained by weekly supplementation of all
cultures with irradiated CAF, spleen cells and antigen . Cultures were tested periodically
for the presence of cells proliferating specifically to AR-BGG presented on syngeneic
spleen cells . Selected cultures were cloned by limiting dilution in Falcon 3040 microtiter
plates (Falcon Labware, Oxnard, CA) containing 5 X 105-106 irradiated spleen cells and
50 ttg/ml AR-BGG in DME with 10% fetal calf serum, 20% P388D, supernatant as a
source of interleukin 1 (IL-1) (25, 26) and 2% concanavalin A (Con A)-depleted spleen
conditioned medium as a source of IL-2 (27) . Clones were tested for specific proliferation
to AR-BGG presented on syngeneic spleen cells. All clones selected for expansion recog-
nized the arsonate hapten on several different carrier proteins . Their surface phenotype
was Thy-I+Ly-1+Ly-2 - using the unlabeled antibody method (27) .
Cell Lines.
￿
The cell lines ORA Ia (28), WEHI-3 (29), P815 (30), P388D, (31), and
M12.4.1 (32) were grown in RPMI 1640 supplemented with 5% fetal calf serum . The
cloned monocyte/macrophage-like cell ORA Ia was obtained from Dr . C . Reinisch, Tufts
University Medical Center and the clonedB cell lymphoma M 12 .4.1 from Dr . L . Glimcher,
Massachusetts General Hospital, Boston . ORA Ia, WEHI-3, P388D,, and M12.4 .1 cells
present antigen to clones Lyl/A5 and Lyl/A7, as assayed by specific production of IL-2
(see Figs . 5, 6) . P815 cells, although of H-2d haplotype, do not express Ia antigens (27)
and do not present antigen to the clones. For most experiments requiring macrophage-
like APC, the cloned ORA Ia cells were used in preference to WEHI-3 or P388D, . Most
or all ORA cells are Ia' by fluorescence (27), and 80-100% are killed by monoclonal
antibodies to I-Ad or I-Ed plus complement, in contrast to only 10-30% of the WEHI-3
and P388D, sublines maintained in this laboratory . Levels of Ia expression on ORA cells
are stable over time ; on WEHI-3 and P388D, Ia expression is normally low, but can be
induced by incubation with T cell supernatants (unpublished results) .
Proliferation Assays .
￿
The response ofT cell clones to antigen and APC was measured
as [3H]thymidine uptake ("proliferation") (27) . 5 X 105 irradiated spleen cells (2,000 rad)
or 104 irradiated (13,000 rad) or mitomycin C-treated (50,ug/ml, 30 min, 37°C) tumor
cells were incubated in microtiter wells with 2-5 X 104 T cells and antigen in 0 .2 ml DME
with 5% fetal calfserum, 2 MM t,-glutamine, 50yM 2-mercaptoethanol, and 1 mM Hepes
(assay medium) . Cells were pulsed at 20-25 h with I ACi [ H]thymidine (New England
Nuclear, Boston, MA) and harvested at 35-40 h . Results are plotted as the mean [ 3H]-
thymidine uptake in duplicate or triplicate wells.
Production ofLymphokine-containing Supernatants.
￿
5 X 10' cloned T cells were incubated
in 0.2 ml assay medium with (a) 100 tag/ml AR-BGG and 106 irradiated CAF, spleen cells
(or adherent cells derived from them) ; (b) 100 jug/ml AR-BGG and 105 irradiated or
mitomycin C-treated ORA cells ; or (c) 2 Ag/ml Con A . Supernatants were harvested at 15RAO ET AL.
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h; their content of IL-2 (and of MAF) was approximately equal.
Lymphokine Assays.
￿
IL-2 was assayed, as previously described, by its ability to support
proliferation of an IL-2-dependent T cell clone (27). MAF was assayed as described (6);
briefly, T cell supernatants were incubated in duplicate wells with 3 X 10' ORA cells or
with adherent cells derived from 2 X 105 resident (unelicited) peritoneal macrophages
from CAF, or B6 mice. After incubation for 20 h to allow macrophage activation, 3 X
10' "Cr-labeled P815 cells were added together with 5 X 10-8 M phorbol myristate
acetate (PMA) as a trigger for cytolysis. 5 'Cr released into the supernatant was measured
20 h after the addition of target cells. The percent specific lysis was calculated from the
mean "Cr release in duplicate or triplicate wells, as [(release in experimental wells -
spontaneous release) X 100]/(maximal release - spontaneous release) (26). Maximal
release was measured after treatment with 2% Nonidet P-40 or 3N HCI.
Bystander Cell Lysis.
￿
In a variant of the MAF assay, T cell clones were examined for
their ability to both activate and trigger cytolysis. 5 X 10' cloned T cells were incubated
with 3 X 10' 5'Cr-P815 cells, antigen, and APC [(a) adherent cells from 2 X 105 resident
peritoneal macrophages; (b) 105 irradiated or mitomycin C-treated ORA or M 12.4.1 cells;
(c) 106 bacillus Calmette-Guerin (BCG)-activated peritoneal cellsobtained as described (7);
or (d) ORA cells or peritoneal adherent cellsactivated with T cell supernatants as described
above]. In some experiments, the APC were pulsed with antigen (37 °C, 1 h) and excess
free antigen was removed by washing. 5'Cr released into the supernatant was measured
at 20 h for nonactivated cells, and at 4-6 h for cells activated with BCG in vivo or with T
cell supernatants in vitro. Percent specific lysis was calculated as described above.
Estimation ofSurviving T Cells After Culture with ORA Cells and Antigen.
￿
3-5 X 10' cloned
T cells, 3 X 10' irradiated or mitomycin C-treated ORA cells, and the indicated concen-
trations ofantigen were incubated in 0.2 ml ofassay medium in round-bottomed microtiter
wells. Excess antigen was removed by washing after 1-16 h. ORA cells pulsed with antigen
(37 ° C, 1 h) were equally effective. 2-3 d later, 5 X 105 irradiated CAF, spleen cells and
30-50,ug/ml AR-BGG were added to all wells. The wells were pulsed with [8H]thymidine
and harvested as for a standard proliferation assay. [8H]thymidine incorporation was taken
as an estimate of the number of surviving T cells.
Results
Characteristics and Specificity of T Cell Clones.
￿
Arsonate-specific inducer T cell
clones were derived from CAF, mice immunized with AR-KLH . Clones LyI/A5
and Lyl/A7, used for these experiments, recognize AR conjugates of several
different carrier proteins but not the structurally similar SA conjugates (Fig.
1 A). Both clones also recognize I-Ad (Fig. 1 B). Upon stimulation, the clones
rapidly release a variety of lymphokines (these promote growth of T cells, mast
cells, and B cells, cause differentiation of thymocytes into cytolytic cells, and
increase la expression and activity of APC (manuscript in preparation)). In this
report we focus on the biologic effects of MAF.
Production of MAF by Inducer T Cell Clones.
￿
After stimulation with Con A or
antigen-pulsed APC, clones Lyl/A5 and Lyl/A7 produce MAF that activate
peritoneal adherent cells to lyse "Cr-labeled tumor cells (Fig. 2). Active super-
natants (produced by incubation of the clones with Con A or antigen-pulsed
APC) were added to cultures of resident peritoneal adherent cells, and 24 h later
"Cr-labeled P815 target cells were added together with PMA as a trigger for
cytolysis. Fig. 2 shows that T cell supernatants contain MAF activity, since
incubation of peritoneal cells with increasing amounts of supernatant results in
increasing lysis of P815 target cells in the presence of the PMA trigger. Incuba-
tion with PMA alone or supernatant alone does not cause detectable lysis (Fig.
2), showing that both steps, activation and triggering, are necessary for lysis of1246
￿
LYSIS OF INDUCERT CELL CLONES BY ACTIVATED MACROPHAGES
; 120
.0
x
E 100
a
U
C
O
0 a
80
roo
40
A.
SA-BGG
20
￿
40
￿
60
￿
80
￿
100 l 200
Antigen Concentration,,ug/ml
FIGURE 1 .
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Antigen and MHC specificity of CI .Lyl/A5. (A) 5 x 10' C1.Lyl/A5 cells were
incubated with 5 X 105 irradiated CAF, spleen cells and the indicated concentrations of
antigen. (B) Cultures contained 5 X 10' Cl.LyI/A5, 5 X 105 irradiated CAF, spleen cells, 100
A&/ml AR-BGG, and the purified monoclonal antibodies MKD6 (anti-I-Ad) and 14.4.4 (anti-1-
E'). [8H]thymidine incorporation was measured between 24 and 40 h.
N
m
a- 40
16
N
;, 30
J
2
d n
a
50
20
10
CAF,
" Resident PEC
10
200
￿
_____.o
E
￿
anti I-Ed
a
U
p 150-
0 0 a v
100
c
c v
-E r L
50
M 0
e .
00 1.5 5 15 50
Final Concentration of Supernatant
anti 1-Ad _
0.02 0.2 2.0 20
Antibody Concentration, jig/ml
FIGURE 2. Production of MAF by CI.Lyl/A5 in response to Con A. Supernatants were
obtained from 5 X 10' CI.Lyl/A5 cells incubated with 2 Ag/ml Con A in 0.2 ml medium for
15 h (see Materials and Methods). Adherent cells derived from 2 x 105 resident CAF,
peritoneal macrophages were incubated with the indicated concentrations of supernatant for
24 h. 3 x 10' 5'Cr-labeled P815 cells were then added together with 5 x 10-8 M PMA to
trigger cytolysis. "Cr released into the supernatant was measured 20 h later. (0) PMA, (/)no
triggering agent. Spontaneous lysis of P815 was 28%d. Similar results were obtained with
supernatants from Cl.Lyl/A7 or with supernatants obtained after stimulation of the clones
with antigen and APC.
P815 cells by peritoneal macrophages.
Inducer T cells produce MAF only after precise corecognition of antigen and
I-A, or after stimulation by Con A. However, once produced, MAF activates
macrophages from mice of various H-2 haplotypes (4, 6; not shown).
Triggering of Activated Macrophages by Inducer T Cells.
￿
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cells activates macrophages but does not trigger cytolysis (Fig. 2) . In contrast, T
cells themselves can trigger lytic activity if they corecognize antigen and I-A on
the surface of activated macrophages (Fig. 3, Table 1). Activated peritoneal
macrophages expressing I-Ad
, which were lytic for P815 cells in the presence of
PMA, were obtained from BCG-injected CAF, mice. The T cell clones Lyl/A5
and Lyl/A7 can rapidly trigger these cells to lyse P815 target cells in the
presence of AR-BGG, but not in the absence of antigen or in the presence of the
nonstimulatory antigen, SA-BGG (Fig. 3). AR-BGG in the absence of T cells
does not stimulate cytolysis. Lysis is dependent on the presence of peritoneal
cells; T cells plus AR-BGG alone do not mediate lysis (Fig. 3) .
In addition to recognition of antigen, lysis required corecognition by the
inducer T cells of the correct I region product on the surface of the activated
macrophages (Table I). Resident peritoneal macrophages from BALB/c and
A/J mice were activated by incubation with T cell supernatants. They were
then triggered to lyse
5 'Cr-labeled P815 target cells by the addition of clone
Ly1/A5 and AR-BGG, or PMA. Table I shows that PMA can trigger lysis by
activated peritoneal adherent cells from both BALB/c and A/J mice, while
Cl. Ly 1/A5 triggers lysis only by activated BALB/c cells, which, unlike A/J cells,
express the stimulatory protein I-Ad (Table 1) . Lysis triggered by PMA is similar
in magnitude to that triggered by the T cell clone and antigen (Table 1) .
Nonactivated BALB/c cells do not mediate lysis (not shown).
These findings demonstrate that cytolysis is triggered by inducer T cells after
specific corecognition of antigen and class 11 molecules on activated peritoneal
cells. Since production of MAF is also stimulated by corecognition (Fig. 2), we
found, as expected, that CI.Lyl/A5 would sequentially activate and trigger I-Ad-
bearing peritoneal adherent cells after 16-20 h of in vitro incubation (measured
by lysis of bystander P815 cells). Again lysis depended on incubation of the clone
with AR-BGG and adherent cells bearing I-Ad (not shown). Use of the cloned B
cell line M12 .4 .1 to present antigen showed that the T cell clone did not itself
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FIGURE 3.
￿
CI.Lyl/A5 can trigger cytolysis by BCG-activated H-2d peritoneal macrophages
in thepresence ofappropriate antigen. 106peritoneal cells from CAF, mice injected with BCG
were incubated with 7 x 10' CI.Lyl/A5, 3 x 104 5ICr-P815 cells, and antigen. "Cr released
into thesupernatant wasmeasured in duplicate wells4 h later. (0) CI.Lyl/A5 + AR-BGG; (p)
Cl.Ly1/A5+ SA-BGG; (O) AR-BGG, no CI.Lyl/A5;(/)Cl.Lyl/A5 + AR-BGG, no peritoneal
cells. Spontaneous lysis of P815 was 11 %.1248
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TABLE I
Lysis ofBystander P815 Cells by Activated and Triggered Peritoneal
Adherent Cells
Adherent cells derived from 2 x 105 resting peritoneal cells from
BALB/c or A/J mice were activated by incubation in 0.1 ml with 50%
MAF-containing supernatants from CI.LyI/A5 stimulated with 2 ug/ml
Con A. 24 h later, 3 x 10' "Cr-labeled P815 cells were added together
with 5 x 10-'M PMA or 3 x I0'CI.LyI/A5 cellsand 50 vg/ml AR-BGG
as indicated. "Cr-release was measured 6 h later in triplicate wells. Spon-
taneous release was 9%.
mediate lysis of P815 cells after stimulation (see Use of Cloned APC Lines) .
Lysis of Inducer T Cells by Activated Macrophages.
￿
We then asked how the
development of cytolytic activity by adherent cells affected activation and sub-
sequent proliferation of the inducer T cell itself. Increasing numbers of C1 .Lyl/
A5 cells were added to antigen-pulsed adherent cells from the spleen or perito-
neal cavity (the clones are normally expanded on irradiated splenic adherent
cells) . We measured activation of the T cell as (a) IL-2 production, which occurs
within the first 16 h, and is a direct measure of the number of activated T cells
(33); (b) DNA synthesis, i.e ., incorporation of [3H]thymidine between 24 and 40
h; and (c) numbers of viable T cells after 50 h in culture.
T cells incubated with peritoneal adherent cells incorporated about 10-fold
less [3H]thymidine in response to antigen than T cells incubated with splenic
adherent cells (Fig. 4B). Since decreased DNA synthesis can reflect noncytolytic
inhibitory processes, we also measured T cell viability by trypan blue exclusion.
Numbers of viable T cells decreased by ^-50% after incubation with antigen-
pulsed peritoneal adherent cells, but increased as expected after incubation with
antigen-pulsed splenic cells (Table II). These effects cannot be ascribed to lack
of activation by peritoneal APC, since both spleen and peritoneal adherent cells
stimulated production of equivalent amounts of IL-2 in the first 18 h (Fig. 4A,
Table II). Control experiments show that spleen and peritoneal cells neither
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FIGURE 4.
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Stimulation of Cl.Ly1/A5 by peritoneal and splenic APC. 105 irradiated CAF,
spleen cellsor 3 x 105 irradiated CAF, peritoneal cells were pulsed (37°C, 1 h) with 50 wg/ml
AR-BGG. Nonadherent cells and excess antigen were removed by washing, and graded
numbers of Cl .Lyl/A5 were added to the wells. (A) Supernatants were removed at 15 h for
assay of IL-2 production; (B) [SHlthymidine uptake (proliferation) was measured between 20
and 40 h. IL-2 in thesupernatants was measured as [5H]thymidine uptake by an IL-2-dependent
Ly2+ T cell clone, exposed to a 20% finalconcentration of the supernatants (27).
TABLE II
Decrease in Viable Cl.Ly1/A7 CellsAfterActivation on Peritoneal as
Compared with Splenic Antigenpulsed Adherent Cells
Adherent cells
￿
IL-2
￿
Number of viable T cells production
U/ml
Splenic
￿
0.33
￿
1.87 x 106(1 .76-1.98)
Peritoneal
￿
0.38
￿
0.56 x 106(0.44-0.68)
107 spleen cellsor 106resting peritoneal cells(2,000 rad) were pulsed with
50 jug/ml AR-BGG (37'C, 1 h). Excess antigen andnonadherent cellswere
removed by washing. 106 Cl.Ly1/A7 cells were added in 1 ml medium.
Samplesofsupernatant were removedat 18 handassayed for IL-2 content
(27), using spleen Con A-conditioned medium as a standard (1 U/ml). At
50 h the number of viable Cl.Ly1/A7 cells was estimated by trypan blue
exclusion. The values given are the mean of duplicate wells (range in
parentheses). Control experiments showed that antigen-pulsed splenic and
peritoneal adherent cells did not produce IL-2 in the absence of T cells
(<0.02 U/ml in 18 h) and that they did not absorb appreciable amounts
of IL.-2from culture mediacontaining supernatant from ConA-stimulated
Cl.Lyl/A5 cells (0.05 and 0.02 U/ml absorbed by splenic and peritoneal
adherent cells, respectively, in 18 hat 37'C). Theresultsare representative
of threesimilar experiments.
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produce IL-2 in the absence of T cells, nor absorb IL-2, even if activated by
MAF present in CI.LyI/A5 supernatant (Table 1I). The release of IL-2 after
incubation with peritoneal adherent cells cannot be attributed to release from
dying T cells alone, since inducer T cells produce 20- to 100-fold more IL-2
after specific immunological stimulation than they release after lysis by cytolytic
cells (27). In sum, although IL-2 production is similar in both cases, activation
by splenic adherent cells results in clonal expansion while activation by peritoneal
adherent cells results in depletion of inducer T cells.
Use of Cloned APC Lines.
￿
Does the same subset of adherent cells that can
activate T cell clones also mediate their lysis? One approach to this question was1250
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to compare the cloned APC ORA la and M12 .4.1, which resemble macrophages
and B cells, respectively (28, 32).
Although both ORA and M12.4.1 cells can activate Cl.LyI/A5 to produce IL-
2 (Figs. 5 and 6), ORA cells develop cytolytic activity whereas M12.4.1 cells do
not (Fig. 7B). Lysis by ORA cells depends on the presence of Cl.LyI/A5 and
AR-BGG, but does not occur in cultures containing Cl .LyI/A5 and SA-BGG
(Fig. 7A). As in the case of peritoneal macrophages, lysis by ORA cells was
divisible into two steps: activation and triggering (not shown) . Thus, we have
shown that (a) a single I-A+ cell type (exemplified by the cloned monocyte/
macrophage-like ORA cells) can initially activate inducer cells via corecognition
of antigen, and later develop cytolytic capacity; (b) development of cytolysis
requires not only activation of the inducer T cell but also presence of the
appropriate APC (ORA vs. M12.4.1).
We measured viability of inducer T cell clones in cultures containing ORA
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FIGURE 5.
￿
Death of Cl.LyI/A5 afteractivation with macrophage-like APC andantigen . 5 X
10' CI .Lyl/A5 cells were incubated with 10' irradiated ORA cells, 3 X 10' irradiated WEHI-
3 cells, or 5 X 105 irradiated CAF, spleen cells and antigen. IL-2 production (A) and DNA
synthesis (B) were measured as described in the legend to Fig. 4.
FIGURE 6.
￿
Stimulation of Cl.LyI/A5 by the cloned B lymphoma M12.4.1 and antigen. 5 X
10' Cl.LyI/A5 cells were incubated with antigen and 10' mitomycin C-treated M12.4 .1 cells
or an la- variant derived from it (30). IL-2 production (B) and DNA synthesis (A) were
measured as described in Fig. 4.60
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FIGURE 7.
￿
Lysis of bystanderP815 cells by activated and triggered cloned APC. (A) 3 X 104
mitomycin C-treated ORA cellspulsed (37°C, 1 h) with 300 jug/ml AR-BGG or SA-BGG were
incubated with or without 3 x 104 CI.Lyl/A5 cells and 3 x 104 5`Cr-P815 cells for 20 h. (B) 3
x 104 mitomycin C-treated ORA cells or M12 cells were incubated with 3 x 104 Cl.Lyl/A5
cells, 100 jug/nil AR-BGG, and 3 X 104 51Cr-P815 cells for 20 h. Release is plotted as mean
specific lysis ± SEM. intriplicate wells. Spontaneous lysis of P815 was 30%.
TABLE III
Death ofCl.Ly1/A5 in Cultures Containing ORA Cells andAntigen
6 X 105 Cl.Lyl/A5 T cells were incubated with 3.6 X 105 irradiated
(13,000rad) ORA cells and 300 wg/ml AR-BGG or SA-BGG as indicated.
18 h later the number of viable T cells in the cultures was estimated by
trypan blue exclusion. The results are representative of four similar
experiments.
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cells and antigen. We measured T cell viability by trypan blue exclusion rather
than by 5`Cr release, to avoid problems of quantitation caused by high back-
ground release and reabsorption of radiolabel. ORA cells were more efficient
than peritoneal cells at causing T cell death: no viable T cells remained after 18
h of incubation with ORA cells pulsed with AR-BGG (Table 111). Incubation of
Cl.Lyl/A5 with AR-BGG alone, ORA cells alone, or ORA cells pulsed with SA-
BGG did not cause appreciable T cell death. The small decrease in viable T cell
numbers in the latter groups is due to incubation for 18 h in assay medium
lacking IL-2 (Table III).
Death of the T cell clone is a direct consequence of corecognition ofantigen
and I-A on ORA cells (Fig. 8). The number of viable T cells remaining after
initial interaction with irradiated ORA cells was measured as [3H]thymidine
incorporation by the T cells in response to subsequent stimulation by splenic
APC and antigen. Incubation of Cl.Lyl/A5 with AR-BGG alone, ORA cells
Preincubation Number of viable
T cells
Percentinitial
number
AR-BGG 5.2 X 105 87
ORA 3.9 x 105 65
AR-BGG + ORA No live cells 0
SA-BGG + ORA 4.2 x 105 701252
￿
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FIGURE 8. Death of Cl.LyI/A5 in cultures containing ORA cells and antigen. 3 X 10'
CI.LyI/A5 cells were incubated with 3 X 10' irradiated ORA cells andantigen as indicated,
in the presence or absence of monoclonal antibodies to I-Ad (MKD6), I-Ed (14.4.4), and I-Ak
(10.2.16). Antibodies were used at 20 jug/ml with 300 ug/ml AR-BGG. After 16 h of
incubation, antibodies and excess antigens were removed by washing. At 48 h, 5 X 105
irradiated CAF, spleen cells and 50 jug/ml AR-BGG were added to all cultures and [sH]-
thymidine incorporation was measured between 20 and 40 h later.
alone, ORA cells and SA-BGG, or splenic adherent cells and AR-BGG did not
result in loss of subsequent responsiveness to antigen and spleen cells. Incubation
with both ORA cells and AR-BGG caused a dose-dependent decrease in the
subsequent response (Fig. 8). Inclusion of monoclonal antibodies to I-Ad, but not
to I-Ed or I-A'`, during the initial incubation with ORA cells and antigen allowed
Cl. Ly 1/A5 to respond vigorously to the second stimulus (Fig. 8). Taken together,
these results show that corecognition of antigen and I-A on ORA APC leads to
lysis of the inducer T cell clone.
Like ORA cells, two other H-2d monocyte/macrophage-like cell lines,
WEH1-3 and P388D,, also caused rapid T cell death in the presence of antigen
(not shown) . This effect was also apparent when IL-2 production was compared
with [3H]thymidine incorporation (Fig. 5). IL-2 production is a rapid result of
corecognition: peak levels of IL-2 are produced by 12-16 h, while [3H]thymidine
incorporation occurs between 20 and 40 h, after significant loss in viability of T
cells has already occurred (Table III) . CI .Lyl/A5 was incubated with antigen
and either syngeneic spleen cells or the monocyte/macrophage lines WEHI-3,
P388D,, and ORA Ia. Levels of IL-2 production were approximately equal in
all cases (Fig. 5A), but T cells incorporated [3H]thymidine only in cultures
containing splenic APC (Fig. 5B).RAOET AL.
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Discussion
Certain types of APC, when activated by MAF produced by inducer T cells,
can be triggered to lyse neighboring cells (4-10; Figs. 2, 3, and 7; Table I). This
sequence of events plays a central role in resistance to parasites, bacteria, viruses,
and tumor cells (3-16). However, normal host cells at sites of inflammation are
also vulnerable to damage by activated macrophages (17). We have used MAF-
producing inducer T cell clones to determine whether interactions between T
cells and APC, in addition to enhancing immune reactions, mayalso act to curtail
its damaging side effects.
Our studies show that inducer T cell clones which corecognize the arsonate
hapten and I region products release MAF shortly after stimulation, and can
trigger a subset of APC (sensitized by MAF) to express cytolytic activity (Figs. 2,
3, and 7, Table I) This interaction results in lysis of the antigen-specific inducer
clone itself (Tables II and III, Fig. 8). Corecognition (the normal stimulus for
clonal expansion) is required forboth steps in this sequence, theinitial production
of MAF (4-6 ; not shown) and subsequent triggering of macrophage cytolysis
(Figs. 3 and 7, Table 1). The most significant aspect of this mechanism is that
the initial cell-cell interaction necessary for maximal lysis of inducer T cell clones
(Table 111, Fig. 8) is precisely the same as for optimal activation, i.e., incubation
with I-Ad-bearing APC and AR-BGG, but not the nonstimulatory analogue SA-
BGG (Fig. 1). T cell lysis may preferentially occur as a result of cell-cell contact
(8): (a) lysis cannot be mediated by supernatants from activated T cells (Fig. 2)
or activated macrophages (not shown); (b) the specific inducer clone (which
interacts with activated macrophages via corecognition) is more efficiently lysed
than `bystander' P815 cells (which are at least as susceptible to macrophage-
mediated lysis [34] ; compare Table III and Figs. 5 and 8 with Fig. 7; Fig. 4 with
Figs. 2 and 3). The physiological consequences ofthese interactions are decreased
duration and intensity of macrophage-mediated lysis, which depends on the
continued presence of inducer T cells (10), and selective depletion of clones of
T cells which corecognize foreign determinants and thus activate macrophage-
mediated immunity.
Studies of immunological memory suggest that this mechanism may operate
in vivo. Infection of mice with Listeria monocytogenes produces activated macro-
phages that are highly cytolytic and eliminate infecting organisms (4, 11, 13-
15). However, persistence of immunity after primary infection with Listeria is
weak and variable. High levels of adoptive immunity can be transferred by T
lymphocytes obtained 6 d after primary infection, but not by lymphocytes
obtained on the 10th and subsequent days (11, 13-15).
Morphological studies on the immune response in lymph nodes suggest that
this mechanism regulates antimicrobial reactions in vivo (35). Strong lymphopro-
liferative responses are seen in draining lymph nodes after footpad injections of
attenuated paratyphoid organisms (35) . This is followed by a rapid increase in
dead lymphocytes and phagocytic macrophages that is particularly evident in
germinal centers and T-dependent areas of the node (35).
The immune response to bacteria and parasites requires the presence of
phagocytic macrophages, since phagocytosis and subsequent "processing" is re-
quired forefficient presentation ofbacterial antigens (36) . Hence, the mechanism1254
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described here maybe particularly important in regulating damage to host tissues
during microbial infections by activated and phagocytic macrophages. In con-
trast, activated macrophages are not a major component of the response to viral
or protein antigens, perhaps because such antigens are preferentially presented
to inducer cells by nonphagocytic APC (dendritic cells; 37). In these cases,
inducer T cells may be inactivated by other means, such as production of Ly-2+
T suppressor cells (38), as well as a nonlytic interaction with APC resulting in
loss of inducer function (39).
Our experiments with I-A+ cell lines suggest that, while certain cells (such as
theB cell-like M12 .4.1) activate lymphokine production and expansion ofinducer
T cell clones (Figs. 6 and 7), others (such as the macrophage-like ORA la)
specifically activate and deplete these clones (Figs. 5 and 8, Table 111). Walker
et al. (45) and McKean et al. (46) have also observed that I-A+ macrophage lines
are less effective than B cell linesat stimulating DNA synthesisby antigen-specific
lymph node T cells and long-term T cell lines, although they can specifically
stimulate T cell hybridomas to produce IL-2 (48, 49). In these experiments,
macrophage-like APC stimulated heterogeneous T cell populations to incorpo-
rate [ 3H]thymidine (45). Our analysis suggests that this may reflect initial pro-
duction of lymphokines by antigen-specific cells (48, 49 ; Fig. 5), and subsequent
activation of other cells in the culture (47). An important conclusion is that IL-
2 production is a more reliable measure than DNA synthesis of the activation of
T cell clones by macrophage-like APC; however, DNA synthesis is preferable as
an index of clonal expansion.
Like I-A+ cell lines, I-A+ nonneoplastic cells purified from lymphoid tissues
may also differ in their ability to activate and expand inducer T cells. Steinman
et al . (40) and Nussenzweig et al. (41) have shown that macrophages from spleen
and peritoneum do not initiate a primary immune response, even though they
may display high levels of I-A after incubation with T cell lymphokines. In
contrast, nonphagocytic I-A+ splenic dendritic cells stimulate [3H]thymidine
incorporation in a primary mixed lymphocyte culture and provide accessory
function for the generation of TNP-specific cytolytic T cells (40-43). Another
study shows that APC from spleen and lymph nodes, but not peritoneal adherent
cells or bone marrow macrophages, stimulate [3H]thymidine incorporation by
long-term T cell lines reactive to myelin basic protein (44) .
We have not examined cloned "dendritic" cell lines such as those derived from
the P388 tumor (50). One type of clone derived from the heterogenous P388
cell line stimulates allogenic and syngeneic mixed lymphocyte reactions (MLR),
and has morphological and functional characteristics of dendritic cells (50); a
second type expresses equivalent amounts of I-A but does not stimulate in a
primary MLR (50). These clones should be examined for sensitization by MAF
and expression of lytic activity triggered by inducer cells.
Lysis of inducer clones by macrophage-like cell lines occurred rapidly after
corecognition (Table III, Fig. 5). In contrast, analysis of peritoneal adherent cells
suggested a slower "cytostatic" effect (10, 17). Although [3H]thymidine incor-
poration between 24 and 40 h was diminished by 90% compared with cultures
supplemented with splenic adherent cells (Fig. 4), T cell viability decreased moreRAO ET AL.
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slowly, to 50% in 50 h (Table I1). Activated peritoneal macrophages have similar
effects on tumor cells: DNA synthesis is rapidly inhibited while cell death occurs
much later (10, 17). We have not determined the possible mechanisms of
cytostasis or lysis (7-9, 12, 16) in our experiments. Lipoxygenase and cyclooxy-
genase inhibitors (BW755C, 100 yM, and indomethacin, 100 j,M) have no effect,
suggesting that arachidonic acid metabolites are not involved.
Splenic adherent cells, which contain both macrophages and dendritic cells
(37), permit T cell expansion. This may be because the APC subset permitting
T cell proliferation is dominant in mixed cultures. We have found that mixtures
of splenic adherent cells and ORA cells (containing numbers of ORA cells that
alone would have lysed all T cells) activate T cell clones as efficiently as splenic
adherent cells alone (measured by [3H]thymidine incorporation; unpublished
results) .
A second possibility raised by these studies is that splenic macrophages, unlike
peritoneal macrophages, do not mediate cell lysis. Macrophages from different
tissues, or at different stages of development, are differentially sensitive to
activation by lymphokines (10, 17). Once present, the ability to respond to MAF
and mediate lysis may be a stable property. This is indicated both by studies of
cell lines (6 and this paper) and of differentiated resident macrophages from
various tissues (10). We are currently comparingperitoneal macrophages, splenic
macrophages, and splenic dendritic cells for cytolytic function after exposure to
MAF.
Summary
We describe a sequence of reciprocal interactions between cloned inducer T
cells and antigen-presenting cells (APC) that results in selective depletion of the
antigen-reactive inducer cells. We show that corecognition of antigen and I-A
by hapten-reactive inducer T cell clones results in (a) release of macrophage-
activating factor (MAF) and other lymphokines, (b) expression oflytic activity by
a subset of MAF-sensitized APC after triggering, and (3) lysis (mediated by the
activated and triggered macrophage) of the inducer T cell clone and other cells
in the vicinity. We suggest that this sequence of steps may limit the extent of
macrophage-mediated tissue destruction by depleting the specific inducer T cell
clones that initiate the response.
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